Quality of Life After Surgery for Rectal Cancer: a Comparison of Functional Outcomes After Transanal and Laparoscopic Approaches
The aim in rectal cancer surgery is to cure with minimal impact on the quality of life. Transanal total mesorectal excision (TaTME) seems to be a safe and feasible alternative to laparoscopic TME (LaTME). However, limited data are available on the functional outcomes after TaTME. We aimed to study the quality of life (QoL), through questionnaires, comparing different functional outcomes after TaTME and LaTME.
Consecutive patients who underwent TME between 2010 and 2017 at Slagelse Hospital, Denmark, were included based on certain criteria. Patients were divided according to the surgical technique (TaTME vs LaTME). The study was based on telephone interviews using the questionnaires: EORTC-QLQ C30, EORTC-QLQ C29, Low Anterior Resection Syndrome (LARS) score, and International Prostate Symptom Score (IPSS) for male patients. Patients in this study had a follow-up time of at least 8 months.
Overall, global health status was similar between the groups (p = 0.625). Anorectal symptoms were significantly in disfavor of TaTME including buttock pain (p = 0.011), diarrhea (p = 0.009), clustering of stools (p = 0.017), and urgency (p = 0.032), yet total LARS score was comparable (p = 0.054). We found comparable sexual results and an overall higher satisfaction with urinary status in TaTME group (p = 0.010), yet no difference in IPSS symptoms (p = 0.236).
Anorectal dysfunction may occur after total mesorectal excision (TME) regardless of surgical technique, frequently more in after TaTME. The LARS symptoms and the overall quality of life status were however comparable. TaTME had a positive impact on the reported QoL, related to urinary symptoms.
KeywordsRectal cancer TaTME LaTME Quality of life Surgery Functional results
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 3.Perdawood SK, Al Khefagie GAA. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis Off J Assoc Coloproctology G B Irel. January 2016;18(1):51–8.Google Scholar
- 4.Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, m.fl. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. December 2016;42(12):1841–50.Google Scholar
- 5.Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis Off J Assoc Coloproctology G B Irel. January 2016;18(1):19–36.Google Scholar
- 6.Bjorn MX, Perdawood SK. Transanal total mesorectal excision--a systematic review. Dan Med J. July 2015;62(7).Google Scholar
- 7.Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, m.fl. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet Lond Engl. 7. March 2009;373(9666):821–8.CrossRefGoogle Scholar
- 13.Rasmussen OO, Petersen IK, Christiansen J. Anorectal function following low anterior resection. Colorectal Dis Off J Assoc Coloproctology G B Irel. May 2003;5(3):258–61.Google Scholar
- 15.Fayers PM AN, Bjordal K, et al. The EORTC QLQ-C30 Scoring Manual (3rd Edition). Eur Organ Res Treat Cancer. 2001;Google Scholar
- 17.Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, m.fl. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer Oxf Engl 1990. November 2009;45(17):3017–26.Google Scholar
- 18.Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, m.fl. Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated by Transanal Total Mesorectal Excision: Results From the International TaTME Registry. Ann Surg. 5. January 2018;Google Scholar
- 19.Chen TY-T, Wiltink LM, Nout RA, Meershoek-Klein Kranenbarg E, Laurberg S, Marijnen CAM, m.fl. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer. June 2015;14(2):106–14.CrossRefGoogle Scholar
- 20.Jimenez-Gomez LM, Espin-Basany E, Marti-Gallostra M, Sanchez-Garcia JL, Vallribera-Valls F, Armengol-Carrasco M. Low anterior resection syndrome: a survey of the members of the American Society of Colon and Rectal Surgeons (ASCRS), the Spanish Association of Surgeons (AEC), and the Spanish Society of Coloproctology (AECP). Int J Colorectal Dis. April 2016;31(4):813–23.CrossRefGoogle Scholar
- 22.Biviano I, Balla A, Badiali D, Quaresima S, D’Ambrosio G, Lezoche E, m.fl. Anal function after endoluminal locoregional resection by transanal endoscopic microsurgery and radiotherapy for rectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel. June 2017;19(6):O177–85.Google Scholar
- 25.Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, Tuynman JB, m.fl. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc. 2. July 2018;Google Scholar
- 28.Juul T, Battersby NJ, Christensen P, Janjua AZ, Branagan G, Laurberg S, m.fl. Validation of the English translation of the low anterior resection syndrome score. Colorectal Dis Off J Assoc Coloproctology G B Irel. October 2015;17(10):908–16.Google Scholar
- 29.Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, m.fl. Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Ann Surg. 4. October 2016;Google Scholar